FIGURE 4.

BanLec inhibits production of early HIV-1 reverse transcription products in peripheral blood lymphocytes. Peripheral blood lymphocytes were treated with different lectin concentrations 30 min before infection with HIV-1 Bru. Three hours post-infection, cellular DNA of the infected cells was harvested, and strong-stop DNA was quantified by real-time PCR. The number of copies was normalized to a PBS-treated control (100%). The known anti-HIV lectin GNA (circles) was used as a positive control and to assess the relative molar potency of BanLec (squares).